Zevra Therapeutics (ZVRA) Receivables - Other (2018 - 2024)
Historic Receivables - Other for Zevra Therapeutics (ZVRA) over the last 8 years, with Q4 2024 value amounting to $333000.0.
- Zevra Therapeutics' Receivables - Other fell 7352.94% to $333000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $333000.0, marking a year-over-year decrease of 7352.94%. This contributed to the annual value of $333000.0 for FY2024, which is 7352.94% down from last year.
- Zevra Therapeutics' Receivables - Other amounted to $333000.0 in Q4 2024, which was down 7352.94% from $1.3 million recorded in Q4 2023.
- Zevra Therapeutics' Receivables - Other's 5-year high stood at $1.3 million during Q4 2023, with a 5-year trough of $107000.0 in Q4 2021.
- For the 5-year period, Zevra Therapeutics' Receivables - Other averaged around $504454.5, with its median value being $400000.0 (2021).
- As far as peak fluctuations go, Zevra Therapeutics' Receivables - Other skyrocketed by 94112.15% in 2022, and later plummeted by 7352.94% in 2024.
- Zevra Therapeutics' Receivables - Other (Quarter) stood at $137000.0 in 2020, then decreased by 21.9% to $107000.0 in 2021, then soared by 941.12% to $1.1 million in 2022, then grew by 12.93% to $1.3 million in 2023, then plummeted by 73.53% to $333000.0 in 2024.
- Its Receivables - Other was $333000.0 in Q4 2024, compared to $1.3 million in Q4 2023 and $700000.0 in Q1 2023.